News

Filter

Current filters:

OncologyAsia-Pacific

1 to 9 of 207 results

Kyowa Hakko Kirin to commercialize Syndax’ entinostat in Japan and Korea

Kyowa Hakko Kirin to commercialize Syndax’ entinostat in Japan and Korea

08-01-2015

Shares of Japanese mid-size drugmaker Kyowa Hakko Kirin rose 3.55% to 1,138 yen by afternoon trading…

Asia-PacificentinostatJapanKyowa Hakko KirinLicensingOncologyPharmaceuticalSyndax Pharmaceuticals

Ariad co-opts Otsuka for Iclusig in Japan and other Asian countries

Ariad co-opts Otsuka for Iclusig in Japan and other Asian countries

24-12-2014

US specialty pharma firm Ariad Pharmaceuticals has entered into an agreement for Japan’s Otsuka Pharmaceuticals…

Ariad PharmaceuticalsAsia-PacificBiotechnologyIclusigJapanLicensingOncologyOtsuka PharmaceuticalResearch

Report: Colorectal cancer market in Asia-Pacific region set to reach $3 billion by 2020

Report: Colorectal cancer market in Asia-Pacific region set to reach $3 billion by 2020

18-12-2014

The Colorectal Cancer (CRC) therapeutics market in Asia-Pacific (APAC) is set to increase in value, from…

AmgenAsia-PacificBiotechnologyDanDrit BiotechEli LillyMarkets & MarketingMelCancerVacOncologyVectibixXBiotechXilonix

Nanobiotix to receive $1 million milestone after global trial expanded

Nanobiotix to receive $1 million milestone after global trial expanded

08-10-2014

French nanomedicine company Nanobiotix says that its partner PharmaEngine will join its pivotal trial…

Asia-PacificFranceNanobiotixNBTXR3OncologyPharmaceuticalPharmaEngineResearch

Green Cross Neulapeg biosimilar approved in South Korea

28-08-2014

South Korea’s Green Cross says that the country’s Ministry of Food and Drug Safety has granted marketing…

AmgenAsia-PacificBiosimilarsBiotechnologyGreen CrossNeulapegNeulastaOncologyRegulation

Bristol-Myers and Ono Pharma enter Asia oncology accord

Bristol-Myers and Ono Pharma enter Asia oncology accord

24-07-2014

US pharma major Bristol-Myers Squibb and Japan’s Ono Pharmaceutical have signed a strategic collaboration…

Asia-PacificBristol-Myers SquibbJapanLicensinglirilumabMelanomaOncologyOno PharmaceuticalOpdivoPharmaceuticalurelumabYervoy

SillaJen changes its name to mark Jennerex acquisition

20-06-2014

South Korean privately held pharma company SillaJen has changed its name to SillaJen Biotherapeutics…

Asia-PacificJennerexManagementMergers & AcquisitionsOncologyPexa-VecPharmaceuticalSillaJen

1 to 9 of 207 results

Back to top